Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: A report by MSKCC and the KIRC TCGA research network.
Clinical Cancer Research.
Times cited: 128
Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma.
Times cited: 100
- Reply from authors re: James W.F. Catto, Shahrokh F. Shariat. the changing face of renal cell carcinoma: The impact of systematic genetic sequencing on our understanding of this tumor's biology. Eur Urol 2013;63:855-7: Genetic stratification of clear cell renal carcinomas presenting as small renal masses. European Urology. 2013 Comment GET IT